Fabry disease trials in Poland
2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleLow dose corticosteroids adjacent to enzyme replacement therapy or chaperon therapy in patients with cardiac manifestation of Fabry disease
- Where
- Katowice, Lodz
- Age
- 18 years and over
- People
- 40
- Run by
- Medical University Of Lodz
See details and how to join2025-521408-24-00 · EU 2025-521408-24-00 - No phaseTaking peopleFabry Disease Registry & Pregnancy Sub-registry
- Where
- Warsaw
- People
- 9,000 worldwide
- Run by
- Genzyme, a Sanofi Company
See details and how to joinNCT00196742